Special Report of the Third Conference on Retroviruses and Opportunistic Invections NEW!

By Jules Levin, Executive Director of NATAP

---

Update on Merck's Indinavir (CRIXIVAN™)

Update on Abbott's Ritonavir (NOVIR™)

Update on Agouron's Nelfinavir (VIRACEPT™)

---

This document was written by Jules Levin, Executive Director of NATAP

Go to the HIV Protease Inhibitor Report Menu

Go to the Protease Inhibitor Menu

Go to the Treatment Menu

Go to the HIVpositive.us Main Menu

39